Vectus Biosystems
(ASX) VBS
Vectus Biosystems Financials at a Glance
Market Cap
$6.41M
Revenue (TTM)
$968.68K
Net Income (TTM)
$3.67M
EPS (TTM)
$-0.03
P/E Ratio
-4.55
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.11
Volume
4,500
Open
$0.11
Price
$0.11
Volume
4,500
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.04 - $0.46
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$0.11
Volume
4,500
Open
$0.11
Previous Close
$0.11
Daily Range
$0.11 - $0.11
52-Week Range
$0.04 - $0.46
VBS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vectus Biosystems
Industry
Biotechnology
Sector
Health CareCEO
Karen Duggan, MD
Website
www.vectusbiosystems.com.auHeadquarters
Rosebery, NSW 2018, AU
VBS Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-16%
Net Income Margin
-17%
Return on Equity
-289%
Return on Capital
4%
Return on Assets
-3%
Earnings Yield
-21.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.41M
Shares Outstanding
53.43M
Volume
4.50K
Avg. Volume
18.05K
Financials (TTM)
Gross Profit
$478.18K
Operating Income
$1.69M
EBITDA
$1.69M
Operating Cash Flow
$830.09K
Capital Expenditure
$0.00
Free Cash Flow
$830.09K
Cash & ST Invst.
$250.99K
Total Debt
$200.00K
Vectus Biosystems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$1.58K
-100.3%
Gross Margin
0.00%
N/A
Market Cap
$6.41M
N/A
Market Cap/Employee
$1.28M
N/A
Employees
5
N/A
Net Income
$731.69K
+37.9%
EBITDA
$714.05K
+37.7%
Quarterly Fundamentals
Net Cash
$136.60K
-106.6%
Accounts Receivable
$14.64K
-98.2%
Inventory
$0.00
-100.0%
Long Term Debt
$467.10K
+1603.0%
Short Term Debt
$0.00
N/A
Return on Assets
-3.05%
N/A
Return on Invested Capital
4.15%
N/A
Free Cash Flow
$170.49K
+80.2%
Operating Cash Flow
$170.49K
+77.8%